Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
Clinical trial NCT00041626 · UNKNOWN
Trial details
- NCT number
- NCT00041626
- Sponsor
- Introgen Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.